CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based ...

A cutting-edge review explores the convergence of three-dimensional (3D) printing and peptide self-assembly, unveiling a new era in biomanufacturing. This technology paves the way for creating ...

D Bioprinting Market OutlookThe global 3D bioprinting market is poised to witness robust growth at a CAGR of 12–15% over the next five years, reflecting its rising significance in modern healthcare ...

Researchers create biodegradable heart valves using shape-memory polymers and 3D bioprinting for safer cardiovascular procedures.

TissueFab ® GelMA-Vis-LAP bioink is a gelatin methacryloyl (GelMA)-based bioink designed for 3D bioprinting applications. In this process, LAP is employed as the photoinitiator, facilitating blue ...

GelMA is a polymerizable hydrogel material generated from natural extracellular matrix (ECM) components. Gelatin has become popular for tissue engineering applications due to its low cost, ...

The 3D printing company's recent acquisition marks its commercial entrance into the burgeoning bioprinting space, in which it had previously been involved only through a research collaboration. While ...

Bioprinting is an additive manufacturing (AM) method for producing biological materials that can be used in medicine, as well as other industries. In the latest advance in this relatively new field, ...

As additive manufacturing has continued along the path of maturity, it has become strikingly clear the young technology excels when applied to the custom work of building intricate components. With ...

REHOVOT, Israel, Nov. 15, 2021 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue ...